ImmunoGen, Inc. (IMGN)
(Delayed Data from NSDQ)
$2.88 USD
+0.38 (15.20%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.93 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For IMGN
-
ImmunoGen (IMGN) Q3 Earnings Beat, Elahere Drives Revenues
-
ImmunoGen (IMGN) Q3 Earnings and Revenues Top Estimates
-
ImmunoGen: Q3 Earnings Snapshot
-
ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results
-
ImmunoGen (IMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
ImmunoGen (IMGN) Stock Down Despite Q2 Earnings & Sales Beat
-
ImmunoGen (IMGN) Reports Q2 Loss, Tops Revenue Estimates
-
ImmunoGen: Q2 Earnings Snapshot
-
ImmunoGen Reports Recent Progress and Second Quarter 2023 Financial Results
-
ImmunoGen (IMGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
-
ImmunoGen (IMGN) Q1 Earnings Beat, Elahere Uptake Encouraging
-
ImmunoGen (IMGN) Reports Q1 Loss, Tops Revenue Estimates
-
ImmunoGen: Q1 Earnings Snapshot
-
ImmunoGen Reports Recent Progress and First Quarter 2023 Financial Results
-
Earnings Preview: ImmunoGen (IMGN) Q1 Earnings Expected to Decline
-
ImmunoGen (IMGN) Down 16.6% Since Last Earnings Report: Can It Rebound?
-
ImmunoGen: Q4 Earnings Snapshot
-
ImmunoGen (IMGN) Reports Q4 Loss, Tops Revenue Estimates
-
Analysts Estimate ImmunoGen (IMGN) to Report a Decline in Earnings: What to Look Out for
-
ImmunoGen (IMGN) Q3 Loss Wider, Sales Beat, '22 View Up
-
ImmunoGen (IMGN) Reports Q3 Loss, Tops Revenue Estimates
-
ImmunoGen: Q3 Earnings Snapshot
-
ImmunoGen Reports Recent Progress and Third Quarter 2022 Financial Results
-
ImmunoGen (IMGN) Expected to Beat Earnings Estimates: Should You Buy?
-
ImmunoGen (IMGN) Q2 Earnings and Revenues Miss Estimates